The biotechnology company reported that a drug meant to treat the skin condition hidradenitis suppurativa, or HS, didn’t have a statistically significant effect.
Continue Reading
View Comments
MoonLake Immunotherapeutics Stock Collapses. Why It’s Down 88%.
Published 1 month ago
Sep 29, 2025 at 12:40 PM
Neutral
Auto